Zinc in PDB 5edi: Human PDE10A, 6-Chloro-5,8-Dimethyl-2-[2-(2-Methyl-5-Pyrrolidin-1-Yl- 2H-[1,2,4]Triazol-3-Yl)-Ethyl]-[1,2,4]Triazolo[1,5-A]Pyridine, 2.20A, H3, Rfree=23.5%
Enzymatic activity of Human PDE10A, 6-Chloro-5,8-Dimethyl-2-[2-(2-Methyl-5-Pyrrolidin-1-Yl- 2H-[1,2,4]Triazol-3-Yl)-Ethyl]-[1,2,4]Triazolo[1,5-A]Pyridine, 2.20A, H3, Rfree=23.5%
All present enzymatic activity of Human PDE10A, 6-Chloro-5,8-Dimethyl-2-[2-(2-Methyl-5-Pyrrolidin-1-Yl- 2H-[1,2,4]Triazol-3-Yl)-Ethyl]-[1,2,4]Triazolo[1,5-A]Pyridine, 2.20A, H3, Rfree=23.5%:
3.1.4.17;
3.1.4.35;
Protein crystallography data
The structure of Human PDE10A, 6-Chloro-5,8-Dimethyl-2-[2-(2-Methyl-5-Pyrrolidin-1-Yl- 2H-[1,2,4]Triazol-3-Yl)-Ethyl]-[1,2,4]Triazolo[1,5-A]Pyridine, 2.20A, H3, Rfree=23.5%, PDB code: 5edi
was solved by
C.Joseph,
M.G.Rudolph,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
43.60 /
2.20
|
Space group
|
H 3
|
Cell size a, b, c (Å), α, β, γ (°)
|
135.231,
135.231,
235.395,
90.00,
90.00,
120.00
|
R / Rfree (%)
|
18.6 /
23.5
|
Other elements in 5edi:
The structure of Human PDE10A, 6-Chloro-5,8-Dimethyl-2-[2-(2-Methyl-5-Pyrrolidin-1-Yl- 2H-[1,2,4]Triazol-3-Yl)-Ethyl]-[1,2,4]Triazolo[1,5-A]Pyridine, 2.20A, H3, Rfree=23.5% also contains other interesting chemical elements:
Zinc Binding Sites:
The binding sites of Zinc atom in the Human PDE10A, 6-Chloro-5,8-Dimethyl-2-[2-(2-Methyl-5-Pyrrolidin-1-Yl- 2H-[1,2,4]Triazol-3-Yl)-Ethyl]-[1,2,4]Triazolo[1,5-A]Pyridine, 2.20A, H3, Rfree=23.5%
(pdb code 5edi). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 4 binding sites of Zinc where determined in the
Human PDE10A, 6-Chloro-5,8-Dimethyl-2-[2-(2-Methyl-5-Pyrrolidin-1-Yl- 2H-[1,2,4]Triazol-3-Yl)-Ethyl]-[1,2,4]Triazolo[1,5-A]Pyridine, 2.20A, H3, Rfree=23.5%, PDB code: 5edi:
Jump to Zinc binding site number:
1;
2;
3;
4;
Zinc binding site 1 out
of 4 in 5edi
Go back to
Zinc Binding Sites List in 5edi
Zinc binding site 1 out
of 4 in the Human PDE10A, 6-Chloro-5,8-Dimethyl-2-[2-(2-Methyl-5-Pyrrolidin-1-Yl- 2H-[1,2,4]Triazol-3-Yl)-Ethyl]-[1,2,4]Triazolo[1,5-A]Pyridine, 2.20A, H3, Rfree=23.5%
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Human PDE10A, 6-Chloro-5,8-Dimethyl-2-[2-(2-Methyl-5-Pyrrolidin-1-Yl- 2H-[1,2,4]Triazol-3-Yl)-Ethyl]-[1,2,4]Triazolo[1,5-A]Pyridine, 2.20A, H3, Rfree=23.5% within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn801
b:40.5
occ:1.00
|
NE2
|
A:HIS563
|
2.1
|
33.1
|
1.0
|
O
|
A:HOH953
|
2.1
|
34.9
|
1.0
|
OD2
|
A:ASP564
|
2.2
|
39.1
|
1.0
|
OD1
|
A:ASP674
|
2.2
|
39.4
|
1.0
|
NE2
|
A:HIS529
|
2.2
|
40.6
|
1.0
|
O
|
A:HOH960
|
2.4
|
46.5
|
1.0
|
CD2
|
A:HIS563
|
3.0
|
34.1
|
1.0
|
CG
|
A:ASP674
|
3.0
|
38.4
|
1.0
|
CG
|
A:ASP564
|
3.1
|
37.0
|
1.0
|
CD2
|
A:HIS529
|
3.1
|
37.0
|
1.0
|
CE1
|
A:HIS563
|
3.1
|
33.9
|
1.0
|
OD2
|
A:ASP674
|
3.2
|
36.9
|
1.0
|
CE1
|
A:HIS529
|
3.2
|
37.3
|
1.0
|
OD1
|
A:ASP564
|
3.5
|
35.7
|
1.0
|
MG
|
A:MG802
|
3.7
|
35.6
|
1.0
|
CD2
|
A:HIS525
|
4.1
|
39.9
|
1.0
|
CG
|
A:HIS563
|
4.1
|
32.9
|
1.0
|
ND1
|
A:HIS563
|
4.2
|
31.0
|
1.0
|
O
|
A:HOH973
|
4.3
|
31.9
|
1.0
|
O
|
A:HOH942
|
4.3
|
49.8
|
1.0
|
CG
|
A:HIS529
|
4.3
|
40.2
|
1.0
|
ND1
|
A:HIS529
|
4.3
|
38.6
|
1.0
|
CB
|
A:ASP564
|
4.4
|
32.2
|
1.0
|
CB
|
A:ASP674
|
4.5
|
36.0
|
1.0
|
NE2
|
A:HIS525
|
4.5
|
37.1
|
1.0
|
O
|
A:HOH911
|
4.5
|
27.4
|
1.0
|
CG2
|
A:VAL533
|
4.7
|
31.2
|
1.0
|
O
|
A:ASP674
|
4.9
|
38.6
|
1.0
|
CA
|
A:ASP674
|
4.9
|
37.7
|
1.0
|
|
Zinc binding site 2 out
of 4 in 5edi
Go back to
Zinc Binding Sites List in 5edi
Zinc binding site 2 out
of 4 in the Human PDE10A, 6-Chloro-5,8-Dimethyl-2-[2-(2-Methyl-5-Pyrrolidin-1-Yl- 2H-[1,2,4]Triazol-3-Yl)-Ethyl]-[1,2,4]Triazolo[1,5-A]Pyridine, 2.20A, H3, Rfree=23.5%
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Human PDE10A, 6-Chloro-5,8-Dimethyl-2-[2-(2-Methyl-5-Pyrrolidin-1-Yl- 2H-[1,2,4]Triazol-3-Yl)-Ethyl]-[1,2,4]Triazolo[1,5-A]Pyridine, 2.20A, H3, Rfree=23.5% within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn801
b:39.6
occ:1.00
|
O
|
B:HOH960
|
2.0
|
24.8
|
1.0
|
NE2
|
B:HIS563
|
2.1
|
32.8
|
1.0
|
NE2
|
B:HIS529
|
2.1
|
29.7
|
1.0
|
OD1
|
B:ASP674
|
2.2
|
36.0
|
1.0
|
OD2
|
B:ASP564
|
2.2
|
33.3
|
1.0
|
O
|
B:HOH977
|
2.4
|
47.2
|
1.0
|
CD2
|
B:HIS529
|
3.0
|
34.4
|
1.0
|
CD2
|
B:HIS563
|
3.0
|
34.8
|
1.0
|
CG
|
B:ASP674
|
3.1
|
35.7
|
1.0
|
CE1
|
B:HIS563
|
3.1
|
32.5
|
1.0
|
CE1
|
B:HIS529
|
3.2
|
33.4
|
1.0
|
CG
|
B:ASP564
|
3.2
|
30.9
|
1.0
|
OD2
|
B:ASP674
|
3.3
|
33.3
|
1.0
|
OD1
|
B:ASP564
|
3.6
|
30.6
|
1.0
|
MG
|
B:MG802
|
3.8
|
29.6
|
1.0
|
CD2
|
B:HIS525
|
4.0
|
41.4
|
1.0
|
O
|
B:HOH979
|
4.1
|
31.0
|
1.0
|
ND1
|
B:HIS563
|
4.2
|
31.9
|
1.0
|
CG
|
B:HIS563
|
4.2
|
33.4
|
1.0
|
O
|
B:HOH949
|
4.2
|
37.0
|
1.0
|
CG
|
B:HIS529
|
4.2
|
32.8
|
1.0
|
ND1
|
B:HIS529
|
4.2
|
32.7
|
1.0
|
NE2
|
B:HIS525
|
4.4
|
43.5
|
1.0
|
CB
|
B:ASP674
|
4.4
|
32.7
|
1.0
|
CB
|
B:ASP564
|
4.5
|
31.2
|
1.0
|
O
|
B:HOH922
|
4.6
|
34.3
|
1.0
|
CG2
|
B:VAL533
|
4.8
|
32.1
|
1.0
|
CA
|
B:ASP674
|
4.9
|
31.6
|
1.0
|
O
|
B:ASP674
|
4.9
|
34.1
|
1.0
|
|
Zinc binding site 3 out
of 4 in 5edi
Go back to
Zinc Binding Sites List in 5edi
Zinc binding site 3 out
of 4 in the Human PDE10A, 6-Chloro-5,8-Dimethyl-2-[2-(2-Methyl-5-Pyrrolidin-1-Yl- 2H-[1,2,4]Triazol-3-Yl)-Ethyl]-[1,2,4]Triazolo[1,5-A]Pyridine, 2.20A, H3, Rfree=23.5%
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 3 of Human PDE10A, 6-Chloro-5,8-Dimethyl-2-[2-(2-Methyl-5-Pyrrolidin-1-Yl- 2H-[1,2,4]Triazol-3-Yl)-Ethyl]-[1,2,4]Triazolo[1,5-A]Pyridine, 2.20A, H3, Rfree=23.5% within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Zn801
b:40.7
occ:1.00
|
O
|
C:HOH925
|
2.0
|
28.9
|
1.0
|
OD2
|
C:ASP564
|
2.1
|
38.6
|
1.0
|
NE2
|
C:HIS529
|
2.2
|
34.9
|
1.0
|
OD1
|
C:ASP674
|
2.2
|
35.1
|
1.0
|
NE2
|
C:HIS563
|
2.2
|
32.5
|
1.0
|
O
|
C:HOH938
|
2.5
|
52.0
|
1.0
|
CD2
|
C:HIS563
|
3.1
|
30.1
|
1.0
|
CG
|
C:ASP564
|
3.1
|
36.9
|
1.0
|
CG
|
C:ASP674
|
3.1
|
36.4
|
1.0
|
CD2
|
C:HIS529
|
3.1
|
32.8
|
1.0
|
CE1
|
C:HIS529
|
3.2
|
33.1
|
1.0
|
CE1
|
C:HIS563
|
3.3
|
32.4
|
1.0
|
OD2
|
C:ASP674
|
3.3
|
41.5
|
1.0
|
OD1
|
C:ASP564
|
3.6
|
35.7
|
1.0
|
MG
|
C:MG802
|
3.8
|
32.9
|
1.0
|
CD2
|
C:HIS525
|
4.0
|
38.1
|
1.0
|
O
|
C:HOH975
|
4.2
|
34.4
|
1.0
|
CG
|
C:HIS563
|
4.3
|
31.4
|
1.0
|
ND1
|
C:HIS529
|
4.3
|
34.1
|
1.0
|
CG
|
C:HIS529
|
4.3
|
31.7
|
1.0
|
CB
|
C:ASP564
|
4.3
|
32.8
|
1.0
|
ND1
|
C:HIS563
|
4.3
|
31.4
|
1.0
|
NE2
|
C:HIS525
|
4.4
|
38.3
|
1.0
|
O
|
C:HOH943
|
4.5
|
44.1
|
1.0
|
CB
|
C:ASP674
|
4.5
|
36.8
|
1.0
|
O
|
C:HOH937
|
4.5
|
37.2
|
1.0
|
O
|
C:HOH1005
|
4.6
|
52.0
|
1.0
|
CG2
|
C:VAL533
|
4.8
|
35.2
|
1.0
|
CA
|
C:ASP674
|
4.9
|
37.4
|
1.0
|
O
|
C:ASP674
|
5.0
|
37.8
|
1.0
|
|
Zinc binding site 4 out
of 4 in 5edi
Go back to
Zinc Binding Sites List in 5edi
Zinc binding site 4 out
of 4 in the Human PDE10A, 6-Chloro-5,8-Dimethyl-2-[2-(2-Methyl-5-Pyrrolidin-1-Yl- 2H-[1,2,4]Triazol-3-Yl)-Ethyl]-[1,2,4]Triazolo[1,5-A]Pyridine, 2.20A, H3, Rfree=23.5%
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 4 of Human PDE10A, 6-Chloro-5,8-Dimethyl-2-[2-(2-Methyl-5-Pyrrolidin-1-Yl- 2H-[1,2,4]Triazol-3-Yl)-Ethyl]-[1,2,4]Triazolo[1,5-A]Pyridine, 2.20A, H3, Rfree=23.5% within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Zn801
b:57.9
occ:1.00
|
NE2
|
D:HIS563
|
2.1
|
46.9
|
1.0
|
O
|
D:HOH927
|
2.1
|
39.3
|
1.0
|
OD2
|
D:ASP564
|
2.2
|
60.5
|
1.0
|
NE2
|
D:HIS529
|
2.2
|
50.1
|
1.0
|
O
|
D:HOH915
|
2.3
|
49.0
|
1.0
|
OD1
|
D:ASP674
|
2.3
|
60.0
|
1.0
|
CD2
|
D:HIS563
|
2.9
|
46.2
|
1.0
|
CD2
|
D:HIS529
|
3.1
|
53.4
|
1.0
|
CG
|
D:ASP674
|
3.1
|
55.1
|
1.0
|
CE1
|
D:HIS563
|
3.2
|
50.2
|
1.0
|
CG
|
D:ASP564
|
3.2
|
50.6
|
1.0
|
CE1
|
D:HIS529
|
3.3
|
51.0
|
1.0
|
OD2
|
D:ASP674
|
3.4
|
56.5
|
1.0
|
OD1
|
D:ASP564
|
3.7
|
51.6
|
1.0
|
MG
|
D:MG802
|
3.8
|
54.8
|
1.0
|
CD2
|
D:HIS525
|
4.1
|
56.6
|
1.0
|
CG
|
D:HIS563
|
4.1
|
48.4
|
1.0
|
O
|
D:HOH920
|
4.2
|
45.9
|
1.0
|
ND1
|
D:HIS563
|
4.2
|
51.2
|
1.0
|
CG
|
D:HIS529
|
4.3
|
48.8
|
1.0
|
CB
|
D:ASP564
|
4.3
|
49.5
|
1.0
|
ND1
|
D:HIS529
|
4.4
|
53.3
|
1.0
|
NE2
|
D:HIS525
|
4.5
|
59.1
|
1.0
|
CB
|
D:ASP674
|
4.5
|
54.9
|
1.0
|
O
|
D:HOH908
|
4.6
|
59.4
|
1.0
|
O
|
D:HOH906
|
4.7
|
51.0
|
1.0
|
CG2
|
D:VAL533
|
4.7
|
44.1
|
1.0
|
O
|
D:ASP674
|
4.9
|
60.6
|
1.0
|
CA
|
D:ASP674
|
4.9
|
57.2
|
1.0
|
|
Reference:
B.Kuhn,
W.Guba,
J.Hert,
D.Banner,
C.Bissantz,
S.Ceccarelli,
W.Haap,
M.Korner,
A.Kuglstatter,
C.Lerner,
P.Mattei,
W.Neidhart,
E.Pinard,
M.G.Rudolph,
T.Schulz-Gasch,
T.Woltering,
M.Stahl.
A Real-World Perspective on Molecular Design. J.Med.Chem. V. 59 4087 2016.
ISSN: ISSN 0022-2623
PubMed: 26878596
DOI: 10.1021/ACS.JMEDCHEM.5B01875
Page generated: Sun Oct 27 15:11:09 2024
|